Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure
Yıl: 2018 Cilt: 19 Sayı: 3 Sayfa Aralığı: 228 - 228 Metin Dili: İngilizce DOI: 10.14744/AnatolJCardiol.2018.05914 İndeks Tarihi: 02-01-2019
Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure
Öz: -
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Editöre Mektup Erişim Türü: Erişime Açık
- Gül İ, Yücel O, Zararsız A, Demirpençe Ö, Yücel H, Zorlu A, et al. Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure. Anatol J Cardiol 2017; 18: 200-5. [CrossRef]
- Ky B, French B, McCloskey K, Rame JE, McIntosh E, Shahi P, et al. High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure. Circ Heart Fail 2011; 4: 180-7. [CrossRef]
- Villacorta H, Maisel AS. Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure. Arq Bras Cardiol 2016; 106: 145-52.
- Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 2007; 116: 627-36. [CrossRef]
- Mueller T, Dieplinger B, Gegenhuber A, Poelz W, Pacher R, Haltmayer M. Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure. Clin Chem 2008; 54: 752-6. [CrossRef]
| APA | ÖNCEL C (2018). Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure. , 228 - 228. 10.14744/AnatolJCardiol.2018.05914 |
| Chicago | ÖNCEL Can Ramazan Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure. (2018): 228 - 228. 10.14744/AnatolJCardiol.2018.05914 |
| MLA | ÖNCEL Can Ramazan Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure. , 2018, ss.228 - 228. 10.14744/AnatolJCardiol.2018.05914 |
| AMA | ÖNCEL C Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure. . 2018; 228 - 228. 10.14744/AnatolJCardiol.2018.05914 |
| Vancouver | ÖNCEL C Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure. . 2018; 228 - 228. 10.14744/AnatolJCardiol.2018.05914 |
| IEEE | ÖNCEL C "Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure." , ss.228 - 228, 2018. 10.14744/AnatolJCardiol.2018.05914 |
| ISNAD | ÖNCEL, Can Ramazan. "Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure". (2018), 228-228. https://doi.org/10.14744/AnatolJCardiol.2018.05914 |
| APA | ÖNCEL C (2018). Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure. The Anatolian Journal of Cardiology, 19(3), 228 - 228. 10.14744/AnatolJCardiol.2018.05914 |
| Chicago | ÖNCEL Can Ramazan Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure. The Anatolian Journal of Cardiology 19, no.3 (2018): 228 - 228. 10.14744/AnatolJCardiol.2018.05914 |
| MLA | ÖNCEL Can Ramazan Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure. The Anatolian Journal of Cardiology, vol.19, no.3, 2018, ss.228 - 228. 10.14744/AnatolJCardiol.2018.05914 |
| AMA | ÖNCEL C Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure. The Anatolian Journal of Cardiology. 2018; 19(3): 228 - 228. 10.14744/AnatolJCardiol.2018.05914 |
| Vancouver | ÖNCEL C Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure. The Anatolian Journal of Cardiology. 2018; 19(3): 228 - 228. 10.14744/AnatolJCardiol.2018.05914 |
| IEEE | ÖNCEL C "Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure." The Anatolian Journal of Cardiology, 19, ss.228 - 228, 2018. 10.14744/AnatolJCardiol.2018.05914 |
| ISNAD | ÖNCEL, Can Ramazan. "Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure". The Anatolian Journal of Cardiology 19/3 (2018), 228-228. https://doi.org/10.14744/AnatolJCardiol.2018.05914 |
